Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah J Marsh

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Journal of Cancer Survivorship : Research and Practice|July 31, 2024
A survey of women diagnosed with breast cancer experiencing oncology treatment-induced hot flushes: identification of specific characteristics as predictors of hot flush occurrence, frequency, and severitySusan Gallagher, Alice Johnstone, Alysha De Livera, et al.
Cancer Letters|October 6, 2024
SMARCA4 and SMARCA2 co-deficiency: An uncommon molecular signature defining a subset of rare, aggressive and undifferentiated malignancies associated with defective chromatin remodelingNatisha R Field, Kristie-Ann Dickson, Najah T Nassif, et al.
Frontiers in Bioengineering and Biotechnology|February 28, 2022
Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized MedicineChristine Yee, Kristie-Ann Dickson, Mohammed N Muntasir, et al.
Cold Spring Harbor Perspectives in Medicine|October 17, 2019
Toward Systems Pathology for PTEN DiagnosticsNahal Haddadi, Glena Travis, Najah T Nassif, et al.
Genes, Chromosomes & Cancer|October 4, 2014
Genomic alterations as mediators of miRNA dysregulation in ovarian cancerCasina W S Kan, Viive M Howell, Michael A Hahn, et al.
Cancers|October 28, 2023
<i>PTEN</i>, <i>PTENP1</i>, microRNAs, and ceRNA Networks: Precision Targeting in Cancer TherapeuticsGlena Travis, Eileen M McGowan, Ann M Simpson, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 7, 2025
Drug repurposing in gynaecological cancers: Proven drugs for new challengesAmani Alghalayini, Farhana A Sarker, Kristie-Ann Dickson, et al.
Breast Cancer Research : BCR|June 18, 2014
Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancerLiping Chung, Katrina Moore, Leo Phillips, et al.
The Journal of Biological Chemistry|July 9, 2011
Involvement of insulin-like growth factor-binding protein-3 in the effects of histone deacetylase inhibitor MS-275 in hepatoma cellsWen Hui Lin, Janet L Martin, Deborah J Marsh, et al.
Clinical Endocrinology|October 12, 2004
K40E: a novel succinate dehydrogenase (SDH)B mutation causing familial phaeochromocytoma and paragangliomaCiara M McDonnell, Diana E Benn, Deborah J Marsh, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Journal of Cancer Survivorship : Research and Practice|July 31, 2024
A survey of women diagnosed with breast cancer experiencing oncology treatment-induced hot flushes: identification of specific characteristics as predictors of hot flush occurrence, frequency, and severitySusan Gallagher, Alice Johnstone, Alysha De Livera, et al.
Cancer Letters|October 6, 2024
SMARCA4 and SMARCA2 co-deficiency: An uncommon molecular signature defining a subset of rare, aggressive and undifferentiated malignancies associated with defective chromatin remodelingNatisha R Field, Kristie-Ann Dickson, Najah T Nassif, et al.
Frontiers in Bioengineering and Biotechnology|February 28, 2022
Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized MedicineChristine Yee, Kristie-Ann Dickson, Mohammed N Muntasir, et al.
Cold Spring Harbor Perspectives in Medicine|October 17, 2019
Toward Systems Pathology for PTEN DiagnosticsNahal Haddadi, Glena Travis, Najah T Nassif, et al.
Genes, Chromosomes & Cancer|October 4, 2014
Genomic alterations as mediators of miRNA dysregulation in ovarian cancerCasina W S Kan, Viive M Howell, Michael A Hahn, et al.
Cancers|October 28, 2023
<i>PTEN</i>, <i>PTENP1</i>, microRNAs, and ceRNA Networks: Precision Targeting in Cancer TherapeuticsGlena Travis, Eileen M McGowan, Ann M Simpson, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 7, 2025
Drug repurposing in gynaecological cancers: Proven drugs for new challengesAmani Alghalayini, Farhana A Sarker, Kristie-Ann Dickson, et al.
Breast Cancer Research : BCR|June 18, 2014
Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancerLiping Chung, Katrina Moore, Leo Phillips, et al.
The Journal of Biological Chemistry|July 9, 2011
Involvement of insulin-like growth factor-binding protein-3 in the effects of histone deacetylase inhibitor MS-275 in hepatoma cellsWen Hui Lin, Janet L Martin, Deborah J Marsh, et al.
Clinical Endocrinology|October 12, 2004
K40E: a novel succinate dehydrogenase (SDH)B mutation causing familial phaeochromocytoma and paragangliomaCiara M McDonnell, Diana E Benn, Deborah J Marsh, et al.
Pageof 7